Butterfly Network Stock
Medical imaging device company
Sign up today and learn more about Butterfly Network Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Butterfly Network Stock
Butterfly Network designs the Butterfly iQ, a handheld single-probe whole-body ultrasound system that connects to a mobile phone or tablet. Butterfly Network's mission is to make ultrasound technology universally accessible and affordable through the sale of its iQ product and memberships. As of March 2020, Butterfly iQ has expanded its commercial presence to 20 markets and is used by over 15,000 healthcare practitioners around the world.
Butterfly Network was founded in 2011 and is headquartered in Guilford, Connecticut.
Investors
Fosun Pharma
Aeris Capital
Bill & Melinda Gates Foundation
Apeel Sciences, Pivot Bio, Butterfly Network, Schrodinger, Evolve Biosystems, Heliogen
Funding History
| March 2012 | $20.8M |
|---|---|
| March 2012 | $20.0M |
| July 2014 | $93.1M |
| July 2018 | $250M |
Management
Co-Founder & Chief Executive Officer
Jonathan M. Rothberg
Co-Founder
Tyler S. Ralston
Co-Founder
Nevada Sanchez
Chief Medical Officer
John Martin
Press
newswire - Mar, 27 2020
Butterfly iQ Now Approved by Health Canadamobihealthnews - Mar, 25 2020
Butterfly rescinds features from handheld ultrasound device, working with FDA to re-enableprnewswire - Dec, 20 2019
Butterfly Network Expands Ultrasound Access with New Offerings from Android and Affirmmobihealthnews - Oct, 24 2019
Butterfly unveils device-agnostic, mobile-friendly ultrasound workflow platformEquityZen Recognized As:
